Bile Duct Injury Management

Clinical Assessment and Diagnosis

Patients experiencing bile vomiting after gallbladder removal should be evaluated for alarm symptoms, including fever, abdominal pain, distention, jaundice, nausea, and vomiting, which may indicate bile duct injury (BDI) or other post-cholecystectomy complications 1
Abdominal ultrasound is the first-line imaging technique for diagnosing acute cholecystitis due to its cost-effectiveness, wide availability, reduced invasiveness, and good accuracy for gallstone disease, with a sensitivity of ~81% and specificity of ~83% for diagnosing gallbladder disease 2, 3, 4, 5

Liver function tests, including direct and indirect bilirubin, AST, ALT, ALP, GGT, and albumin, should be performed to assess liver function 1
In critically ill patients, CRP, PCT, and lactate levels should be checked to evaluate inflammation severity 1
The American College of Surgeons recommends antibiotic therapy as the first line of treatment, with options including amoxicillin/clavulanate, ceftriaxone + metronidazole, and ciprofloxacin + metronidazole for stable patients, and piperacillin/tazobactam, cefepime + metronidazole, ertapenem, and tigecycline for unstable patients 6

Abdominal triphasic CT should be used as first-line imaging to detect fluid collections and ductal dilation 1
Contrast-enhanced MRCP may be considered for exact visualization, localization, and classification of potential BDI 1
MRI with MRCP is recommended for detecting cholelithiasis/choledocholithiasis, with a sensitivity of 85-100% 5
CT with IV contrast is recommended for detecting complications, with a sensitivity of ~75% for gallstones 5, 1

For minor BDIs (Strasberg A-D), observation or percutaneous treatment with drain placement may be considered, with endoscopic management if symptoms worsen or don't improve 1
For major BDIs (Strasberg E1-E2) diagnosed within 72 hours, referral to a center with hepatopancreatobiliary (HPB) expertise is recommended, while those diagnosed between 72 hours and 3 weeks may be managed with percutaneous drainage, targeted antibiotics, and nutritional support 1
The World Society of Emergency Surgery guidelines strongly recommend gallbladder drainage in patients with acute cholecystitis who are not suitable for immediate surgery, as it effectively converts a septic patient into a non-septic patient 2
Percutaneous transhepatic gallbladder drainage (PTGBD) is indicated as the primary intervention in patients with high surgical risk, need for urgent source control, and ability to convert a septic patient to non-septic 2

ERCP with biliary sphincterotomy and stent placement is mandatory for minor BDIs with no improvement after observation or percutaneous drainage, reducing pressure gradient in the biliary tree and effectively treating bile leaks 1
For major BDIs diagnosed early (within 72 hours), urgent surgical repair with bilioenteric anastomosis (Roux-en-Y hepaticojejunostomy) may be required, while those diagnosed later (72 hours to 3 weeks) may require delayed Roux-en-Y hepaticojejunostomy after stabilization 1
Delayed laparoscopic cholecystectomy should be considered after improvement of the patient's condition and reduction of perioperative risks, typically after 4-6 weeks 2
Immediate surgery should not be attempted in patients with a combination of renal failure, coagulopathy, and sepsis due to prohibitively high surgical risk 2

Normal saline (NS) or lactated Ringer's (LR) solution at 10 ml/kg/hour is recommended for initial fluid resuscitation, as suggested by the American Society of Critical Care and the Journal for ImmunoTherapy of Cancer 7, 8
Goal-directed fluid therapy should be used for fluid resuscitation, as recommended by the American Gastroenterological Association and the World Journal of Emergency Surgery 9
Oral nonsteroidal anti-inflammatory drugs (NSAIDs) are recommended as first-line therapy for pain management, with acetaminophen as an alternative or adjunct, with a strength of evidence level of moderate 2, 9

The World Journal of Emergency Surgery recommends no pre-operative antibiotics for Class A or B patients (healthy or with mild systemic disease) 10
The World Journal of Emergency Surgery suggests that pre-operative antibiotics are recommended for patients with moderate to severe cholecystitis (Tokyo Grade II-III) 1
The National Comprehensive Cancer Network recommends lorazepam 0.5-2 mg oral, IV, or sublingual every 4-6 hours as needed for patients with nausea and vomiting 11
The National Comprehensive Cancer Network suggests that H2 blockers or proton pump inhibitors may be added to the regimen for patients with nausea and vomiting 11

Bile duct injuries are among the most serious complications of laparoscopic cholecystectomy, as reported by 12
Gangrenous cholecystitis, emphysematous cholecystitis, gallbladder perforation, and hemorrhagic cholecystitis are potential complications of acute cholangitis, with higher mortality rates in acalculous cholecystitis compared to calculous cholecystitis, as reported by the World Journal of Emergency Surgery guidelines and other studies 12, 4, 2
Patients with uncorrected coagulopathy are at increased risk of intraoperative bleeding, as stated by the Clinical Gastroenterology and Hepatology guidelines 13
Risk factors for conversion to open cholecystectomy include male gender, previous upper abdominal surgery, and advanced age 2